Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.

Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.
复制标题

DOI:
10.1371/journal.pone.0056130
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Chien MH
Chien MH
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Cheng CW;Su JL;Lin CW;Su CW;Shih CH;Yang SF;Chien MH

文献摘要

参考文献

被引文献

相似文献

核因子(NF)-κB的组成性激活在肝细胞癌(HCC)中是常见的。本研究检测了编码NF-κB1的NF KB 1和编码IκBα的NF KBIA启动子区域内的多态性与HCC发生的易感性和肿瘤的临床病理特征的关系。采用实时荧光定量聚合酶链反应(PCR)技术检测135例HCC患者和520例健康对照者的NFKB 1和NFKBIA基因多态性。NFKB 1 - 94 Ins基因多态性在HCC患者中的基因型频率显著高于对照组(校正比值比(AOR)= 2.23,95%可信区间(CI)1.32 ~ 3.77)。  NFKBIA −-519 C/T、-826 C/T或-881 A/G基因型和单倍型多态性在HCC患者和对照组之间的分布频率无统计学意义。此外,携带NFKB 1 - 94 Ins多态性的女性HCC患者与较低的临床分期和较小的肿瘤大小相关。我们的研究结果表明NFKB 1 - 94 Ins启动子多态性增加了女性HCC的风险,并可作为女性HCC患者临床分期和肿瘤大小的预测因子。
Constitutive activation of nuclear factor (NF)-κB is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-κB1 and NFKBIA encoding IκBα with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1 -94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95% confidence interval (CI) 1.32∼3.77). No statistical significance was observed for the distribution frequency of the NFKBIA −-519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.
DOI: 10.1016/s0168-8278(02)00064-8
发表时间: 2002-07-01
影响因子: 25.7
作者:
Liu, P;Kimmoun, E;Bernuau, D
通讯作者: Bernuau, D
DOI: 10.1016/s0304-3835(02)00460-3
发表时间: 2002-12-15
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Curran, JE;Weinstein, SR;Griffiths, LR
通讯作者: Griffiths, LR
DOI: 10.1371/journal.pone.0035078
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Lin CW;Hsieh YS;Hsin CH;Su CW;Lin CH;Wei LH;Yang SF;Chien MH
通讯作者: Chien MH
DOI: 10.1007/s10875-010-9439-9
发表时间: 2010-09-01
影响因子: 9.1
作者:
Li, Ruei-Nian;Hung, Yu-Hung;Yen, Jen-Hsien
通讯作者: Yen, Jen-Hsien
DOI: 10.1093/hmg/ddh008
发表时间: 2004-01-01
影响因子: 3.5
作者:
Karban, AS;Okazaki, T;Brant, SR
通讯作者: Brant, SR